Dr Aiman Abdel-Malekanand
Advisory Council Member
Dr. Aiman Abdel-Malek is currently the Executive Chairman, Advisory Board, Thirdwayv Inc., Irvine California. He served as the Executive Vice President and Chief Technology Officer at Insulet Corporation (NASDAQ: Podd) until April 2019. From March 2016 to February 2018, he was Insulet's Senior Vice President, Advanced Technology and Engineering. Under his leadership, Insulet launched the first FDA cleared smartphone controlled tubeless Insulin patch pump in the world- the Omnipod DASH platform-based connected diabetes management products. Prior to joining Insulet, Aiman served as President of Frictionless Life Analytics, Inc., a business development company that enables the growth of start-up ventures focused on secure Internet of Things (IoT) healthcare solutions. From 2012 to 2015, he served as Vice President of Engineering at Qualcomm Life, Inc., a mobile healthcare solutions Qualcomm company. From 1988 to 2012, he held various executive roles at General Electric, including General Manager - Global Services Technology at GE Healthcare where he launched the first GE predictive services offerings. Dr. Abdel-Malek brings over 20 years of experience as a senior executive, leading healthcare business teams to develop break-through technology-based business solutions.
Aiman holds a Ph.D. in Biomedical Engineering from the University of Southern California. He serves on the Board of Novela Neurotech, Inc. and the University of Pennsylvania PRECISE Center for Safe AI. He has over 30 patents and publications and is a frequent keynote speaker at various digital healthcare, secure IoT, and mobile digital healthcare forums.